These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 26307590)
1. Clarivein mechanochemical ablation of the great and small saphenous vein: Early treatment outcomes of two hospitals. Deijen CL; Schreve MA; Bosma J; de Nie AJ; Leijdekkers VJ; van den Akker PJ; Vahl A Phlebology; 2016 Apr; 31(3):192-7. PubMed ID: 26307590 [TBL] [Abstract][Full Text] [Related]
2. Lower pain and faster treatment with mechanico-chemical endovenous ablation using ClariVein®. Vun SV; Rashid ST; Blest NC; Spark JI Phlebology; 2015 Dec; 30(10):688-92. PubMed ID: 25300311 [TBL] [Abstract][Full Text] [Related]
3. Macroscopic and Histologic Analysis of Vessel Wall Reaction After Mechanochemical Endovenous Ablation Using the ClariVein OC Device in an Animal Model. Boersma D; van Haelst ST; van Eekeren RR; Vink A; Reijnen MM; de Vries JP; de Borst GJ Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):290-298. PubMed ID: 28025005 [TBL] [Abstract][Full Text] [Related]
4. An Italian experience with mechanochemical ablation of the saphenous vein since 2012. Mirandola M; Griso A; Migliara B; Cappellari TF; Giovannini F; Lino M J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):999-1005. PubMed ID: 32179039 [TBL] [Abstract][Full Text] [Related]
5. Mechanochemical endovenous ablation of saphenous veins using the ClariVein: A systematic review. Witte ME; Zeebregts CJ; de Borst GJ; Reijnen MMPJ; Boersma D Phlebology; 2017 Dec; 32(10):649-657. PubMed ID: 28403687 [TBL] [Abstract][Full Text] [Related]
6. Endovenous ablation with concomitant phlebectomy is a safe and effective method of treatment for symptomatic patients with axial reflux and large incompetent tributaries. Harlander-Locke M; Jimenez JC; Lawrence PF; Derubertis BG; Rigberg DA; Gelabert HA J Vasc Surg; 2013 Jul; 58(1):166-72. PubMed ID: 23571079 [TBL] [Abstract][Full Text] [Related]
7. Endovenous mechanochemical ablation of great saphenous vein incompetence using the ClariVein device: a safety study. van Eekeren RR; Boersma D; Elias S; Holewijn S; Werson DA; de Vries JP; Reijnen MM J Endovasc Ther; 2011 Jun; 18(3):328-34. PubMed ID: 21679070 [TBL] [Abstract][Full Text] [Related]
8. Mechanochemical endovenous ablation of small saphenous vein insufficiency using the ClariVein(®) device: one-year results of a prospective series. Boersma D; van Eekeren RR; Werson DA; van der Waal RI; Reijnen MM; de Vries JP Eur J Vasc Endovasc Surg; 2013 Mar; 45(3):299-303. PubMed ID: 23312507 [TBL] [Abstract][Full Text] [Related]
9. Histological observations one year after mechanochemical endovenous ablation of the great saphenous vein. van Eekeren RR; Hillebrands JL; van der Sloot K; de Vries JP; Zeebregts CJ; Reijnen MM J Endovasc Ther; 2014 Jun; 21(3):429-33. PubMed ID: 24915593 [TBL] [Abstract][Full Text] [Related]
10. Endovenous laser ablation versus mechanochemical ablation with ClariVein(®) in the management of superficial venous insufficiency (LAMA trial): study protocol for a randomised controlled trial. Leung CC; Carradice D; Wallace T; Chetter IC Trials; 2016 Aug; 17(1):421. PubMed ID: 27552990 [TBL] [Abstract][Full Text] [Related]
11. Update of endovenous treatment modalities for insufficient saphenous veins--a review of literature. van Eekeren RR; Boersma D; de Vries JP; Zeebregts CJ; Reijnen MM Semin Vasc Surg; 2014 Jun; 27(2):118-36. PubMed ID: 25868763 [TBL] [Abstract][Full Text] [Related]
12. Mechanochemical endovenous ablation versus radiofrequency ablation in the treatment of primary small saphenous vein insufficiency (MESSI trial): study protocol for a randomized controlled trial. Boersma D; van Eekeren RR; Kelder HJ; Werson DA; Holewijn S; Schreve MA; Reijnen MM; de Vries JP Trials; 2014 Oct; 15():421. PubMed ID: 25354769 [TBL] [Abstract][Full Text] [Related]
14. Retrograde mechanochemical ablation of the small saphenous vein for the treatment of a venous ulcer. Moore HM; Lane TR; Franklin IJ; Davies AH Vascular; 2014 Oct; 22(5):375-7. PubMed ID: 24347131 [TBL] [Abstract][Full Text] [Related]
15. ClariVein® - Early results from a large single-centre series of mechanochemical endovenous ablation for varicose veins. Tang TY; Kam JW; Gaunt ME Phlebology; 2017 Feb; 32(1):6-12. PubMed ID: 26908638 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of two novel techniques of nonthermal endovenous ablation of the great saphenous vein. Vos CG; Ünlü Ç; Bosma J; van Vlijmen CJ; de Nie AJ; Schreve MA J Vasc Surg Venous Lymphat Disord; 2017 Nov; 5(6):880-896. PubMed ID: 29037363 [TBL] [Abstract][Full Text] [Related]
17. Two-year results of a multicenter randomized controlled trial comparing Mechanochemical endovenous Ablation to RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial). Holewijn S; van Eekeren RRJP; Vahl A; de Vries JPPM; Reijnen MMPJ; J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):364-374. PubMed ID: 31000063 [TBL] [Abstract][Full Text] [Related]
18. Comparing mechanochemical endovenous ablation using Flebogrif with endovenous laser ablation in the treatment of primary great saphenous vein incompetence: protocol for a multicentre, open-label, non-inferiority, observer-blinded, randomised controlled trial (REBORN trial). Oud S; Alozai T; Schreve MA; Mooij MC; van Vlijmen CJ; Ünlü Ç BMJ Open; 2024 Aug; 14(8):e087490. PubMed ID: 39117408 [TBL] [Abstract][Full Text] [Related]
19. Endovenous laser ablation is an effective treatment for great saphenous vein incompetence in teenagers. Terlecki P; Przywara S; Iłżecki M; Terlecki K; Kawecki P; Zubilewicz T Phlebology; 2016 Apr; 31(3):198-202. PubMed ID: 25940645 [TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, dose-finding study of mechanochemical ablation using ClariVein and liquid polidocanol for great saphenous vein incompetence. Lam YL; Alozai T; Schreve MA; de Smet AAEA; Vahl AC; Nagtzaam I; Lawson JA; Nieman FHM; Wittens CHA J Vasc Surg Venous Lymphat Disord; 2022 Jul; 10(4):856-864.e2. PubMed ID: 34781008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]